siRNA therapy lowers triglycerides in patients with rare condition

  • RESEARCH HIGHLIGHT
  • 19 September 2024

Plozasiran reduced triglyceride levels by 80% and lowered the risk of pancreatitis in patients with persistent chylomicronemia, with or without a genetic diagnosis.